Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Little Green Pharma Ltd. ( (AU:LGP) ) has provided an announcement.
Little Green Pharma Ltd announced an investor webinar to discuss its March quarterly results, reporting a 40% revenue growth for FY25 with $36.6 million in revenue. The company highlighted its acquisition of Health House, contributing $0.8 million in sales, and its ongoing expansion into European and UK markets, which underscores its strategic positioning and growth potential in the global medicinal cannabis industry.
More about Little Green Pharma Ltd.
Little Green Pharma Ltd (ASX:LGP) is a leading global medicinal cannabis company with vertically integrated operations across Europe and Australia. The company offers a diverse portfolio of cannabis-based medicines distributed across Australia and over 12 export markets. LGP operates three production facilities in Denmark and Australia, positioning itself as a key player in global medicinal cannabis markets, with significant supply into France, Germany, and the UK.
Average Trading Volume: 135,628
Technical Sentiment Signal: Sell
Current Market Cap: A$38.01M
For detailed information about LGP stock, go to TipRanks’ Stock Analysis page.